...

CCO Treatment Updates

A Call to Action for Hematology Fellows: Clinical Advances and Patient Considerations in Lymphomas

Module

A Call to Action for Hematology Fellows: Clinical Advances and Patient Considerations in Lymphomas

Faculty:

Alissa Marr, MDJames O. Armitage, MD
  • Alissa Marr, MD
  • James O. Armitage, MD

CREDIT INFORMATION

Release Date: November 16, 2009

Expiration Date: November 15, 2010


Physicians: maximum of 1.0 AMA PRA Category 1 Credit

Status: Please log in to view status

Begin the Module

Alissa Marr, MD, and James O. Armitage, MD, provide an overview of non-Hodgkin’s lymphoma for oncology/hematology fellows.

Learning Objectives

Upon completion of this activity, participants should be able to:

  • Identify important clinical considerations for managing various types of lymphoma patients
  • Discuss the clinical evidence supporting optimal treatment choices for various non-Hodgkin’s lymphoma subtypes
  • Evaluate how to integrate newer agents into the treatment of various non-Hodgkin’s lymphoma subtypes

Abstract

Interactive Virtual Presentation

Therapeutic Approaches in Non-Hodgkin’s Lymphoma: A Case Review

Faculty:

James O. Armitage, MDAlissa Marr, MD
  • James O. Armitage, MD
  • Alissa Marr, MD

CREDIT INFORMATION

Release Date: November 16, 2009

Expiration Date: November 15, 2010


Physicians: maximum of 1.0 AMA PRA Category 1 Credit

Status: Please log in to view status

Begin the Virtual Presentation

James O. Armitage, MD, and Alissa Marr, MD, provide a case-based analysis of optimal management strategies for non-Hodgkin’s lymphoma with an emphasis on diagnosis, prognostic assessment, and treatment.

Learning Objectives

Upon completion of this activity, participants should be able to:

  • Apply guideline recommendations when treating patients with newly diagnosed diffuse large B-cell lymphoma
  • Assess indicators for treatment when managing patients with grade 1 or 2 follicular lymphoma
  • Cite the available treatment options for patients with relapsed mantle cell lymphoma
  • Employ phenotypic data when considering the treatment for patients with anaplastic large-cell lymphoma
  • Explain the diagnostic features of Burkitt’s lymphoma

Slideset: Therapeutic Approaches in Non-Hodgkin’s Lymphoma: A Case Review

Download the Slideset


Review a case-based analysis of optimal management strategies for non-Hodgkin’s lymphoma with an emphasis on diagnosis, prognostic assessment, and treatment.


Format: Microsoft PowerPoint (.ppt) | File size: 1.46 MB | Date posted: 11/16/2009


Disclaimer: The materials published on the Clinical Care Options Sites reflect the views of the reviewers or authors of the CCO material, not those of Clinical Care Options, LLC, the CME provider, or the companies providing educational grants. The materials may discuss uses and dosages for therapeutic products that have not been approved by the United States Food and Drug Administration. A qualified healthcare professional should be consulted before using any therapeutic product discussed. Readers should verify all information and data before treating patients or using any therapies described in these materials.

Jointly sponsored by Postgraduate Institute for Medicine and Clinical Care Options, LLC.

Contact Info

Educational grants provided by:

Educational grants support only the CME-certified components of this program.